These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35668697)

  • 1. COVID-19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona, Spain.
    Vallecillo G; Durán X; Canosa I; Roquer A; Martinez MC; Perelló R
    Drug Alcohol Rev; 2022 Sep; 41(6):1311-1318. PubMed ID: 35668697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race, trust, and COVID-19 vaccine hesitancy in people with opioid use disorder.
    Sullivan MC; Mistler C; Copenhaver MM; Wickersham JA; Ni Z; Kim RS; Shrestha R
    Health Psychol; 2022 Feb; 41(2):115-120. PubMed ID: 34855415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of COVID-19 vaccine hesitancy: questionnaire development and validation.
    Cvjetković S; Jeremić Stojković V; Piperac P; Djurdjević O; Bjegović-Mikanović V
    Cent Eur J Public Health; 2022 Jun; 30(2):99-106. PubMed ID: 35876598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine hesitancy among people with multiple sclerosis.
    Yap SM; Al Hinai M; Gaughan M; Callanan I; Kearney H; Tubridy N; McGuigan C
    Mult Scler Relat Disord; 2021 Nov; 56():103236. PubMed ID: 34507240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination coverage, vaccine hesitancy and opioid use disorder: Correspondence.
    Mungmunpuntipantip R; Wiwanitkit V
    Drug Alcohol Rev; 2023 Jan; 42(1):233. PubMed ID: 35836384
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 vaccine hesitancy among different population groups in China: a national multicenter online survey.
    Huang Y; Su X; Xiao W; Wang H; Si M; Wang W; Gu X; Ma L; Li L; Zhang S; Yang C; Yu Y; Qiao Y
    BMC Infect Dis; 2022 Feb; 22(1):153. PubMed ID: 35164700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Countering COVID-19 Vaccine Hesitancy in Pregnancy: the "4 Cs".
    Shook LL; Kishkovich TP; Edlow AG
    Am J Perinatol; 2022 Jul; 39(10):1048-1054. PubMed ID: 34666378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
    Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hesitancy toward COVID-19 vaccines among medical students in Southwest China: a cross-sectional study.
    Li M; Zheng Y; Luo Y; Ren J; Jiang L; Tang J; Yu X; Luo D; Fan D; Chen Y
    Hum Vaccin Immunother; 2021 Nov; 17(11):4021-4027. PubMed ID: 34357832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explorative study regarding influenza vaccine hesitancy among HIV-infected patients.
    Marchese V; Storti S; Morganti C; Tiecco G; Degli Antoni M; Focà E; Castelli F; Quiros-Roldan E
    Hum Vaccin Immunother; 2022 Nov; 18(5):2046434. PubMed ID: 35357270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying SARS-CoV-2 vaccine hesitancy among health professionals in Tunisia.
    Zammit N; Gueder AE; Brahem A; Ayouni I; Ghammam R; Fredj SB; Sridi C; Chouchene A; Kalboussi H; Maalel OE; Chatti S; Maatoug J; Ghannem H; Mrizak N
    BMC Health Serv Res; 2022 Apr; 22(1):489. PubMed ID: 35413911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.
    Yaseen MO; Saif A; Khan TM; Yaseen M; Saif A; Bukhsh A; Shahid MN; Alsenani F; Tahir H; Ming LC; Amin MU; Suleiman AK; Al-Worafi YM; Baig MR; Saeed Imran M; Jaber AA
    Hum Vaccin Immunother; 2022 Dec; 18(1):2031455. PubMed ID: 35192781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Vaccine Hesitancy and Vaccination Status in a Community-Based Cohort of People Who Inject Drugs in Baltimore, Maryland, March-June 2021.
    Cepeda JA; Feder KA; Astemborski J; Schluth C; Kirk GD; Mehta SH; Genberg BL
    Public Health Rep; 2022; 137(5):1031-1040. PubMed ID: 35848111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
    Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
    Front Immunol; 2021; 12():781161. PubMed ID: 34912346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence of COVID-19 Vaccination and Vaccine Hesitancy in Pregnant Women: An Internet-based Cross-sectional Study in Japan.
    Hosokawa Y; Okawa S; Hori A; Morisaki N; Takahashi Y; Fujiwara T; Nakayama SF; Hamada H; Satoh T; Tabuchi T
    J Epidemiol; 2022 Apr; 32(4):188-194. PubMed ID: 35095091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: A cross-sectional study.
    Kiefer MK; Mehl R; Costantine MM; Johnson A; Cohen J; Summerfield TL; Landon MB; Rood KM; Venkatesh KK
    BJOG; 2022 Jul; 129(8):1342-1351. PubMed ID: 35104382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptance rate and risk perception towards the COVID-19 vaccine in Botswana.
    Tlale LB; Gabaitiri L; Totolo LK; Smith G; Puswane-Katse O; Ramonna E; Mothowaeng B; Tlhakanelo J; Masupe T; Rankgoane-Pono G; Irige J; Mafa F; Kolane S
    PLoS One; 2022; 17(2):e0263375. PubMed ID: 35120163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.